17P (17-hydroxyprogesterone caproate)

17-hydroxyprogesterone caproate · AMAG Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 17P (17-hydroxyprogesterone caproate), covering 2021-01-28 to 2021-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Confirmatory Study of 17P vs Vehicle for Prevention of Preterm Birth in Women w/ Previous Spontaneous Preterm Delivery [Phase 3]

See pricing